Growth Metrics

Evolent Health (EVH) Return on Sales (2016 - 2026)

Evolent Health has reported Return on Sales over the past 11 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 0.01% at Evolent Health, down from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q4 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2021 and later fell -1bps in 2025.
  • Year by year, Return on Sales stood at 0.0% in 2021, then soared by 99bps to 0.0% in 2022, then crashed by -2871bps to 0.0% in 2023, then crashed by -247bps to 0.0% in 2024, then crashed by -2494bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for EVH at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.